StonvexLoading…
StonvexStonvexStonvexCore line items from BLK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.70B | $24.22B | $17.21B | $10.70B |
Operating Income | $2.81B | $7.04B | $5.38B | $3.43B |
Net Income | $2.21B | $5.55B | $4.43B | $3.10B |
EPS (Diluted) | $14.06 | $35.31 | $28.21 | $19.83 |
Total Assets | $170.24B | $170.00B | $162.68B | $146.47B |
Total Liabilities | $106.92B | $108.46B | $100.83B | $94.87B |
Cash & Equivalents | $9.84B | $11.47B | $9.98B | $9.48B |
Free Cash Flow OCF − CapEx | $-1.09B | $3.55B | $1.41B | $69.00M |
Shares Outstanding | 155.36M | 155.07M | 155.12M | 154.75M |